Literature DB >> 26170942

Toll-like receptor 4 blocker as potential therapy for acetaminophen-induced organ failure in mice.

Mohamed Salama1, Mohamed Elgamal2, Azza Abdelaziz3, Moataz Ellithy4, Dina Magdy4, Lina Ali4, Emad Fekry5, Zinab Mohsen2, Mariam Mostafa4, Hoda Elgamal2, Hussein Sheashaa6, Mohamed Sobh7.   

Abstract

Acetaminophen (APAP, 4-hydroxyacetanilide) is the most common cause of acute liver failure in the United States. In addition to exhibiting hepatotoxicity, APAP exerts a nephrotoxic effect may be independent of the induced liver damage. Toll-like receptors (TLRs) have been suggested as a potential class of novel therapeutic targets. The aim of the present study was to investigate the potential of the TLR-4 blocker TAK-242 in the prevention of APAP-induced hepato-renal failure. Four groups of C57BL mice were studied: Vehicle-treated/control (VEH), APAP-treated (APAP), N-acetyl cysteine (NAC)-pretreated plus APAP (APAP + NAC) and TAK-242-pretreated plus APAP (APAP + TAK) groups. Mice were clinically assessed then perfused 4 h later. Liver and kidney tissues were collected and examined histologically using basic hematoxylin and eosin staining to detect signs of necrosis and inflammation. Plasma samples were collected to measure the levels of alanine transaminase, aspartate transaminase and serum creatinine. In addition, liver and kidney tissues were assayed to determine the levels of reduced glutathione. The results of the present study indicate the potential role of TLR-4 in APAP-induced organ toxicity. In the APAP + TAK and APAP + NAC groups, histopathological examination indicated that pretreatment with TAK-242 or NAC afforded protection against APAP-induced injury. However, this protective effect was more clinically evident in the APAP + TAK group compared with the APAP + NAC group. The various biochemical parameters (serum enzymes and reduced glutathione) revealed no significant protection in either of the pretreated groups. Therefore, the present study indicated that the TLR-4 blocker had protective effects against acute APAP toxicity in liver and kidney tissues. These effects were identified clinically, histologically and biochemically. Furthermore, the TLR-4 blocker TAK-242 exhibited antioxidant properties in addition to anti-inflammatory effects.

Entities:  

Keywords:  acetaminophen; hepatotoxicity; nephrotoxicity; toll-like receptor 4

Year:  2015        PMID: 26170942      PMCID: PMC4487059          DOI: 10.3892/etm.2015.2442

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

1.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

2.  Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States.

Authors:  Parivash Nourjah; Syed Rizwanuddin Ahmad; Claudia Karwoski; Mary Willy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2006-06       Impact factor: 2.890

Review 3.  The role of oxidative stress during inflammatory processes.

Authors:  Jérôme Lugrin; Nathalie Rosenblatt-Velin; Roumen Parapanov; Lucas Liaudet
Journal:  Biol Chem       Date:  2014-02       Impact factor: 3.915

Review 4.  TLR2 and TLR4 in ischemia reperfusion injury.

Authors:  F Arslan; B Keogh; P McGuirk; A E Parker
Journal:  Mediators Inflamm       Date:  2010-06-09       Impact factor: 4.711

5.  What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?

Authors:  Louise W Kao; Mark A Kirk; R Brent Furbee; Nimish H Mehta; Jason R Skinner; Edward J Brizendine
Journal:  Ann Emerg Med       Date:  2003-12       Impact factor: 5.721

6.  TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock.

Authors:  Bruno Daubeuf; John Mathison; Stephan Spiller; Stephanie Hugues; Suzanne Herren; Walter Ferlin; Marie Kosco-Vilbois; Hermann Wagner; Carsten J Kirschning; Richard Ulevitch; Greg Elson
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

7.  TLR2, TLR3, and TLR4 activation specifically alters the oxidative status of intestinal epithelial cells.

Authors:  Eva Latorre; Carmen Mendoza; Elena Layunta; Ana I Alcalde; José E Mesonero
Journal:  Cell Stress Chaperones       Date:  2013-09-26       Impact factor: 3.667

8.  Up-regulation of TLR-4 in the brain after ischemic kidney-induced encephalopathy in the rat.

Authors:  Mohamed Salama; Sally Mohamed Farrag; Sarah abulfath abulasrar; Maha Mohamed Amin; Azza Abdel-Aziz Ali; Hussein Sheashaa; Mohamed Sobh; Oscar Arias-Carrión
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-08       Impact factor: 4.388

9.  Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury.

Authors:  Jun Xu; Xiaomei Zhang; Marc Monestier; Naomi L Esmon; Charles T Esmon
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

10.  Toll-like receptor 4 knockout mice are protected against endoplasmic reticulum stress induced by a high-fat diet.

Authors:  Nicolas Pierre; Louise Deldicque; Caroline Barbé; Damien Naslain; Patrice D Cani; Marc Francaux
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

View more
  10 in total

Review 1.  Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity.

Authors:  Carolina I Ghanem; María J Pérez; José E Manautou; Aldo D Mottino
Journal:  Pharmacol Res       Date:  2016-02-26       Impact factor: 7.658

2.  Sapidolide A alleviates acetaminophen-induced acute liver injury by inhibiting NLRP3 inflammasome activation in macrophages.

Authors:  Jin-Cheng Wang; Qi Shi; Qian Zhou; Lu-Lu Zhang; Yue-Ping Qiu; Da-Yong Lou; Li-Qin Zhou; Bo Yang; Qiao-Jun He; Qin-Jie Weng; Jia-Jia Wang
Journal:  Acta Pharmacol Sin       Date:  2022-01-12       Impact factor: 7.169

3.  Alleviative effects from boswellic acid on acetaminophen-induced hepatic injury.

Authors:  Lung-Che Chen; Li-Hong Hu; Mei-Chin Yin
Journal:  Biomedicine (Taipei)       Date:  2016-05-09

4.  Chitohexaose protects against acetaminophen-induced hepatotoxicity in mice.

Authors:  P K Barman; R Mukherjee; B K Prusty; S Suklabaidya; S Senapati; B Ravindran
Journal:  Cell Death Dis       Date:  2016-05-12       Impact factor: 8.469

5.  Alleviative effects from boswellic acid on acetaminophen-induced hepatic injury - Corrected and republished from: Biomedicine (Taipei). 2016 Jun; 6 (2): 9. doi: 10.7603/s40681-016-0009-1PMCID: PMC4864770.

Authors:  Lung-Che Chen; Li-Hong Hu; Mei-Chin Yin
Journal:  Biomedicine (Taipei)       Date:  2017-06-14

6.  Astragalus polysaccharides exerts immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo.

Authors:  Lijing Zhou; Zijing Liu; Zhixue Wang; Shuang Yu; Tingting Long; Xing Zhou; Yixi Bao
Journal:  Sci Rep       Date:  2017-03-17       Impact factor: 4.379

Review 7.  Toll-Like Receptors in Acute Kidney Injury.

Authors:  Cristina Vázquez-Carballo; Melania Guerrero-Hue; Cristina García-Caballero; Sandra Rayego-Mateos; Lucas Opazo-Ríos; José Luis Morgado-Pascual; Carmen Herencia-Bellido; Mercedes Vallejo-Mudarra; Isabel Cortegano; María Luisa Gaspar; Belén de Andrés; Jesús Egido; Juan Antonio Moreno
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

Review 8.  Toll-Like Receptors Regulate the Development and Progression of Renal Diseases.

Authors:  Minghui Liu; Ke Zen
Journal:  Kidney Dis (Basel)       Date:  2020-12-10

9.  Dibromoacetic Acid Induced Hepatotoxicity in Mice through Oxidative Stress and Toll-Like Receptor 4 Signaling Pathway Activation.

Authors:  Tingting Gong; Wenbo Jiang; Zhijian Gao; Yingying Chen; Shuying Gao
Journal:  Oxid Med Cell Longev       Date:  2019-11-20       Impact factor: 6.543

10.  Extract from Mulberry (Morus australis) leaf decelerate acetaminophen induced hepatic inflammation involving downregulation of myeloid differentiation factor 88 (MyD88) signals.

Authors:  Chi-Ting Horng; Zhi-Hong Liu; Yu-Ting Huang; Huei-Jane Lee; Chau-Jong Wang
Journal:  J Food Drug Anal       Date:  2016-11-05       Impact factor: 6.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.